Industry Insights

31. Reading Between The Lines: How To Evaluate Decontamination Cycle Time Claims 8/19/2026

    Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.

32. How Automated Microscopy Systems Improve Analytical Workflows 4/14/2026

    Automated microscopy is helping teams move faster with more consistent imaging. Learn how high-throughput systems reduce variability, support digital workflows, and strengthen decision-making.

33. Closing The QC Gap For mAbs: Rapid Answers Without Compromising 6/9/2026

    Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

34. Software Validation Keeps GxP Systems Current, Speeds Up Time-To-Market 2/2/2024

    Requirements to maintain a GxP environment mean researchers must conduct software validation on any updated software so it continues to meet users’ needs.

35. Why Location Matters 1/5/2023

    While many factors can dictate the choice of a CDMO partner, the CDMO's location can have a significant influence on the communications channels, facilities, and skillsets that a potential partner has to offer.

36. Advancing ADC Development Through Integrated ADME, DDI Strategies 5/8/2026

    Discover how tailored strategies, advanced technologies, and scientifically driven decision frameworks are accelerating the successful development and regulatory readiness of next-generation ADCs.

37. The New FDA Era Of Radical Transparency And Pervasive Oversight 9/9/2025

    The first half of 2025 has been transformative for biopharmaceutical quality and regulatory affairs, with the FDA leading the charge with four significant changes. Curadian Group's David Grote discusses implications for all four.

38. Continuous Processing For Enhanced Monoclonal Antibody Production 9/14/2023

    mAbs have only recently been leveraged for advanced bioprocessing techniques. Explore highlights from a webinar where experts discussed their unique collaboration for the continuous processing of mAbs.

39. Minimizing Changeover Time On Pharmaceutical Isolator Lines 1/11/2022

    Following are examples showing different steps and required times for a standard filling line and elements that can reduce the changeover time to a minimum.

40. COVID-19: 5 Steps To Achieve Situational Awareness In The Pharma Supply Chain 3/26/2020

    To address the current worldwide COVID-19 pandemic, more controls are being imposed by cities, states, and countries. Trucks are being delayed at borders. Flights are being canceled. It is important to be capable of adapting work practices around this ever-changing situation.